111 related articles for article (PubMed ID: 8515683)
1. Regional homovanillic acid production in humans.
Lambert GW; Eisenhofer G; Jennings GL; Esler MD
Life Sci; 1993; 53(1):63-75. PubMed ID: 8515683
[TBL] [Abstract][Full Text] [Related]
2. Regional 5-hydroxyindoleacetic acid production in humans.
Lambert GW; Kaye DM; Cox HS; Vaz M; Turner AG; Jennings GL; Esler MD
Life Sci; 1995; 57(3):255-67. PubMed ID: 7541101
[TBL] [Abstract][Full Text] [Related]
3. Regional origins of 3-methoxy-4-hydroxyphenylglycol in plasma: effects of chronic sympathetic nervous activation and denervation, and acute reflex sympathetic stimulation.
Lambert GW; Kaye DM; Vaz M; Cox HS; Turner AG; Jennings GL; Esler MD
J Auton Nerv Syst; 1995 Nov; 55(3):169-78. PubMed ID: 8801267
[TBL] [Abstract][Full Text] [Related]
4. Direct determination of homovanillic acid release from the human brain, an indicator of central dopaminergic activity.
Lambert GW; Eisenhofer G; Cox HS; Horne M; Kalff V; Kelly M; Jennings GL; Esler MD
Life Sci; 1991; 49(15):1061-72. PubMed ID: 1895870
[TBL] [Abstract][Full Text] [Related]
5. The influence of aging on the plasma concentration and renal clearance of homovanillic acid.
Lambert GW; Eisenhofer G; Esler MD
Psychoneuroendocrinology; 1994; 19(1):33-41. PubMed ID: 9210210
[TBL] [Abstract][Full Text] [Related]
6. Monoaminergic neuronal activity in subcortical brain regions in essential hypertension.
Lambert GW; Ferrier C; Kaye DM; Kalff V; Kelly MJ; Cox HS; Turner AG; Jennings GL; Esler MD
Blood Press; 1994 Mar; 3(1-2):55-66. PubMed ID: 7515310
[TBL] [Abstract][Full Text] [Related]
7. Influence of renal clearance on peripheral homovanillic acid measurements in healthy subjects and schizophrenic patients.
Whelton CL; Gupta RN; Cleghorn JM; Ballagh SR
Schizophr Res; 1993 Dec; 11(1):33-40. PubMed ID: 8297802
[TBL] [Abstract][Full Text] [Related]
8. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
Kendler KS; Heninger GR; Roth RH
Eur J Pharmacol; 1981 May; 71(2-3):321-6. PubMed ID: 7250191
[TBL] [Abstract][Full Text] [Related]
9. Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin.
Sternberg DE; Heninger GR; Roth RH
Life Sci; 1983 May; 32(21):2447-52. PubMed ID: 6855448
[TBL] [Abstract][Full Text] [Related]
10. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients.
Pickar D; Breier A; Kelsoe J
Ann N Y Acad Sci; 1988; 537():339-46. PubMed ID: 2904783
[TBL] [Abstract][Full Text] [Related]
11. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
[TBL] [Abstract][Full Text] [Related]
12. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
[TBL] [Abstract][Full Text] [Related]
13. Effects of renal clearance on plasma concentrations of homovanillic acid. Methodologic cautions.
Potter WZ; Hsiao JK; Goldman SM
Arch Gen Psychiatry; 1989 Jun; 46(6):558-62. PubMed ID: 2730280
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system noradrenergic and dopaminergic turnover in response to acute neuroleptic challenge.
Lambert GW; Horne M; Kalff V; Kelly MJ; Turner AG; Cox HS; Jennings GL; Esler MD
Life Sci; 1995; 56(19):1545-55. PubMed ID: 7723582
[TBL] [Abstract][Full Text] [Related]
15. Control of renal factors in plasma homovanillic acid measurements.
Amin F; Stroe AE; Kahn T; Knott PJ; Kahn RS; Davidson M
Neuropsychopharmacology; 1998 Apr; 18(4):317-20. PubMed ID: 9509499
[TBL] [Abstract][Full Text] [Related]
16. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients.
Konicki PE; Owen RR; Litman RE; Pickar D
Life Sci; 1991; 48(14):1411-6. PubMed ID: 2008157
[TBL] [Abstract][Full Text] [Related]
17. The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects.
Giltay EJ; Kho KH; Blansjaar BA; Verbeek MM; Geurtz PB; Geleijnse JM; Gooren LJ
J Endocrinol; 2005 Oct; 187(1):109-16. PubMed ID: 16214946
[TBL] [Abstract][Full Text] [Related]
18. Influence of dopamine agonists on plasma and brain levels of homovanillic acid.
Kendler KS; Heninger GR; Roth RH
Life Sci; 1982 Jun; 30(24):2063-9. PubMed ID: 7109836
[TBL] [Abstract][Full Text] [Related]
19. Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging.
Amin F; Seeman TE; Mohs RC; Davidson M; Knott P; Berkman LF; Albert M; Blazer D
Neuropsychopharmacology; 1994 Feb; 10(1):29-35. PubMed ID: 8179792
[TBL] [Abstract][Full Text] [Related]
20. The significance of homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations in human lumbar cerebrospinal fluid.
Ebinger G; Michotte Y; Herregodts P
J Neurochem; 1987 Jun; 48(6):1725-9. PubMed ID: 3572399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
